GlaxoSmithKline plc (GSK.L)
-LSE 1,749.50 
7.50(0.43%) May 24, 11:35AM EDT
| Prev Close: | 1,742.00 |
|---|
| Open: | 1,743.50 |
|---|
| Bid: | 1,749.00 |
|---|
| Ask: | 1,750.00 |
|---|
| 1y Target Est: | 1,675.14 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1,726.50 - 1,750.00 |
|---|
| 52wk Range: | 1,314.00 - 1,773.00 |
|---|
| Volume: | 7,816,873 |
|---|
| Avg Vol (3m): | 7,311,570 |
|---|
| Market Cap: | 84.75B |
|---|
| P/E (ttm): | 2,055.82 |
|---|
| EPS (ttm): | 0.85 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Headlines
- German, French Indices Vulnerable at Elevated Levelsat Motley Fool(Thu, May 23)
- Elan rejects Royalty's $6.4 billion raised offerReuters(Thu, May 23)
- Elan rejects Royalty's $6.4 bln raised offerat Reuters(Thu, May 23)
- Royalty cuts acceptance bar for Elan bid to 50 percentat Reuters(Thu, May 23)
- Royalty cuts acceptance bar for Elan bid to 50 pctat Reuters(Thu, May 23)
- GSK flu shot may raise adult narcolepsy risk -Finnish scientistsat Reuters(Thu, May 23)
- Pfizer takes its shot at a vaccine for evasive superbugReuters(Thu, May 23)
- [$$] U.S. to Fund Glaxo's Research on Antibioticsat The Wall Street Journal(Wed, May 22)
- Glaxo, US partnering to develop new antibioticsAP(Wed, May 22)
- 3 Reasons to Love GlaxoSmithKlineat Motley Fool(Wed, May 22)
- U.S. government taps GlaxoSmithKline for new antibioticsat Reuters(Wed, May 22)
- Glaxo to Get Up to $200 Million for U.S. Researchat Bloomberg(Wed, May 22)
- Immune system cancer drugs tipped to be a $35 bln marketat Reuters(Wed, May 22)
- [$$] Glaxo Shuts Australian Packaging Siteat The Wall Street Journal(Wed, May 22)
- What Are the City's Expectations for GlaxoSmithKline's Profits?at Motley Fool(Tue, May 21)
Key Statistics
| Forward P/E (1 yr): | 0.14 |
|---|
| P/S (ttm): | 321.31 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 115.64 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 27.89 |
|---|
| Mean Recommendation*: | 2.7 |
|---|
| PEG Ratio (5 yr expected): | 1.88 |
|---|
Business Summary
GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide.
View More